NCT02455011 — Type 2 Diabetes Mellitus trial site landscape

Public-registry site landscape for NCT02455011, a Type 2 Diabetes Mellitus study sponsored by REMD Biotherapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT02455011 (registry record)
Sponsor	REMD Biotherapeutics, Inc.
Condition(s)	Type 2 Diabetes Mellitus; Diabetes
Phase	PHASE1 / PHASE2
Listed sites	3
Site countries	United States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT02455011 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.